Several other equities analysts have also recently commented on the stock. Citigroup Inc. reissued a buy rating on shares of Roche Holding in a research report on Wednesday, July 27th. Goldman Sachs Group Inc. restated a buy rating on shares of Roche Holding in a report on Tuesday, July 19th.
Roche Holding (VTX:ROG) opened at 239.30 on Tuesday. The firm has a market capitalization of CHK 203.92 billion and a P/E ratio of 22.04. The stock’s 50 day moving average price is CHK 241.62 and its 200-day moving average price is CHK 245.91. Roche Holding has a 12 month low of CHK 229.90 and a 12 month high of CHK 281.40.
About Roche Holding
Roche Holding AG is a research-based healthcare company. The Company develops, manufactures and delivers medicines, and diagnostic instruments and tests. Its operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. Its Pharmaceuticals division consists of two business segments: Roche Pharmaceuticals and Chugai.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.